Carregant...
MET targeted therapy for lung cancer: clinical development and future directions
MET, the receptor for hepatocyte growth factor, has been identified as a novel promising target in various human malignancies, including lung cancer. Research studies have demonstrated that MET signaling plays important physiologic roles in embryogenesis and early development, whereas its deregulati...
Guardat en:
| Publicat a: | Lung Cancer (Auckl) |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5312490/ https://ncbi.nlm.nih.gov/pubmed/28210125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S23423 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|